IGLV3-19
Immunoglobulin lambda variable 3-19
Also known as: LV319_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01714
- Gene
- IGLV3-19
- Ensembl
- ENSG00000211663
- Chromosome
- 22
- Canonical length
- 112 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
112 residues, UniProt reviewed canonical sequence.
>P01714|IGLV3-19
1 MAWTPLWLTL LTLCIGSVVS SELTQDPAVS VALGQTVRIT CQGDSLRSYY ASWYQQKPGQ
61 APVLVIYGKN NRPSGIPDRF SGSSSGNTAS LTITGAQAED EADYYCNSRD SSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLV3-19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1,846 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 1,846 nTPM
- stomach: 1,166 nTPM
- colon: 959 nTPM
- rectum: 852 nTPM
- spleen: 679 nTPM
- duodenum: 672 nTPM
Single-cell type
- plasma cells: 32 nCPM
- gastric chief cells: 22 nCPM
- parietal cells: 11 nCPM
- mucous neck cells: 5.1 nCPM
- erythrocytes: 4.6 nCPM
- foveolar cells: 4.4 nCPM
Immune cell
- memory B-cell: 621 nTPM
- naive B-cell: 506 nTPM
- total PBMC: 36 nTPM
- neutrophil: 1.5 nTPM
- eosinophil: 1 nTPM
- MAIT T-cell: 0.7 nTPM
Brain region
- medulla oblongata: 3.1 nTPM
- white matter: 2 nTPM
- spinal cord: 1.2 nTPM
- thalamus: 0.8 nTPM
- cerebral cortex: 0.6 nTPM
- choroid plexus: 0.6 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLV3-19 as an antibody target. Whether an autoantibody or antibody against IGLV3-19 could matter depends on whether native IGLV3-19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLV3-19 is annotated at the cell surface, where native IGLV3-19 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLV3-19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...